Role of cholinesterase inhibitors in dementia care needs rethinking.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16946340.
- Also identified by PMC identifier 1557932.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The NHS focus on memory clinics driven by drugs that slow cognitive decline is taking resources away from services offering long term integrated care. The role of these clinics needs reconsideration alongside availability of the drugs
Medical subject headings
- Cholinesterase Inhibitors
- Dementia